Confronto

Lanreotid vs. Vasopressin

Due peptidi a confronto — identità, base di evidenze, stato legale ed eventi avversi noti.

Identità

Categoria

Ricerca (altro)

N. CAS

108736-35-2

nessun dato

Peso molecolare

1096.34 g/mol

1084.23 g/mol

Emivita

nessun dato

Sequenza

nessun dato

Meccanismo d'azione

Lanreotid

Lanreotide activates somatostatin receptors (chiefly SSTR2, additionally SSTR5), thereby suppressing the release of growth hormone, IGF-1 and various gastrointestinal and neuroendocrine hormones. It is metabolically far more stable than natural somatostatin.

Vasopressin

Vasopressin binds V1 receptors (vasoconstriction, raising vascular resistance) and V2 receptors (renal water reabsorption via aquaporin channels). This raises blood pressure and acts antidiuretically. Desmopressin is the V2-selective synthetic analog.

Base di evidenze

Evidenza più alta

RCT sull'uomo

Studi

di cui sull'uomo

Effetti registrati

Contraddizioni aperte

Eventi avversi documentati

Stato legale

Country	Lanreotid	Vasopressin
Germania	Su prescrizione	Su prescrizione
Stati Uniti	Su prescrizione	Su prescrizione

Voci complete

Frequently asked questions

What is the difference between Lanreotid and Vasopressin?: Lanreotid is classified as "Ricerca (altro)", while Vasopressin is classified as "Ricerca (altro)". Lanreotid: Lanreotide is a synthetic cyclic octapeptide analog of somatostatin. It binds preferentially to the somatostatin receptors SSTR2 and SSTR5 and is approved for treating acromegaly and certain neuroendocrine tumours. Vasopressin: Vasopressin (arginine vasopressin, antidiuretic hormone/ADH) is a cyclic nonapeptide hormone that regulates water balance and vascular tone. As Vasostrict it is approved to raise blood pressure in vasodilatory shock. This page contrasts both neutrally and source-based — with no usage or dosing recommendation.
Which peptide is better supported by science, Lanreotid or Vasopressin?: The highest available evidence level is "RCT sull'uomo" for Lanreotid and "RCT sull'uomo" for Vasopressin. A higher evidence level means more robust data, but says nothing about suitability for an individual. The full body of evidence is on each peptide's own page.
What is the legal status of Lanreotid and Vasopressin in Germany and the United States?: Germania: Lanreotid — Su prescrizione, Vasopressin — Su prescrizione. Stati Uniti: Lanreotid — Su prescrizione, Vasopressin — Su prescrizione. These are factual summaries with source and review date on the individual pages.

Country

Lanreotid

Vasopressin

Germania

Su prescrizione

Stati Uniti

Su prescrizione

Frequently asked questions

What is the difference between Lanreotid and Vasopressin?

Lanreotid is classified as "Ricerca (altro)", while Vasopressin is classified as "Ricerca (altro)". Lanreotid: Lanreotide is a synthetic cyclic octapeptide analog of somatostatin. It binds preferentially to the somatostatin receptors SSTR2 and SSTR5 and is approved for treating acromegaly and certain neuroendocrine tumours. Vasopressin: Vasopressin (arginine vasopressin, antidiuretic hormone/ADH) is a cyclic nonapeptide hormone that regulates water balance and vascular tone. As Vasostrict it is approved to raise blood pressure in vasodilatory shock. This page contrasts both neutrally and source-based — with no usage or dosing recommendation.

Which peptide is better supported by science, Lanreotid or Vasopressin?

The highest available evidence level is "RCT sull'uomo" for Lanreotid and "RCT sull'uomo" for Vasopressin. A higher evidence level means more robust data, but says nothing about suitability for an individual. The full body of evidence is on each peptide's own page.

What is the legal status of Lanreotid and Vasopressin in Germany and the United States?

Germania: Lanreotid — Su prescrizione, Vasopressin — Su prescrizione. Stati Uniti: Lanreotid — Su prescrizione, Vasopressin — Su prescrizione. These are factual summaries with source and review date on the individual pages.